Is Tharimmune Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: THAR) stock is to Strong Buy THAR stock.
Out of 1 analyst, 1 (100%) are recommending THAR as a Strong Buy, 0 (0%) are recommending THAR as a Buy, 0 (0%) are recommending THAR as a Hold, 0 (0%) are recommending THAR as a Sell, and 0 (0%) are recommending THAR as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year THAR price target, the average THAR price target is $17.00, with the highest THAR stock price forecast at $17.00 and the lowest THAR stock price forecast at $17.00.
The Wall Street analyst predicted that Tharimmune's share price could reach $17.00 by Dec 6, 2025. The average Tharimmune stock price prediction forecasts a potential upside of 1,064.38% from the current THAR share price of $1.46.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.